Gene expression study to elucidate the anti-trypanosomal activity of quinapyramine methyl sulphate (QPS).

The study focuses on understanding how quinapyramine methyl sulphate (QPS), a common treatment for Trypanosoma evansi infections in horses, impacts the gene expression of this parasite, thereby providing insights into its anti-trypanosomal activity.

Understanding the Research

• The research centers on Trypanosoma evansi, a parasite that causes a deadly disease called Surra in equines, bringing significant economic and health issues to the equine industry worldwide. The study specifically looks at how QPS, the traditional treatment for the T. evansi infection, works.
• Despite being used for over 70 years, there’s a lack of understanding about how QPS fights T. evansi. Thanks to the establishment of in vitro cultivation of T. evansi, researchers could examine the changes in mRNA expression when the parasite is exposed to the drug, offering a clearer picture of QPS’s mode of action.

Aim and Methodology of the Study

• The objective of the research was to understand the effect of QPS on 13 significant drug target genes of T. evansi.
• The researchers first determined the amount (IC) of QPS required to inhibit the growth of a pony isolate of T. evansi. The parasite population was then exposed to this concentration of the drug, and the relative mRNA expression of the genes was measured at intervals of 12 hours, 24 hours, and 48 hours.

Key Findings and Implications

• The study found that the mRNA expression of several genes, such as hexokinase, trypanothione reductase, aurora kinase, oligopeptidase B, and ribonucleotide reductase II, did not change significantly on QPS exposure.
• In contrast, the genes related to trans-sialidase, ESAG8, ribonucleotide reductase I, ornithine decarboxylase, topoisomerase II, and casein kinase I significantly increased in expression after QPS exposure. The arginine kinase 1 and calcium ATPase I genes, however, showed a high decrease in expression.
• These findings suggest that the arginine kinase 1 and calcium ATPase I genes may have key roles in the mechanism by which QPS acts against T. evansi. This could open up new avenues for research into the drug’s trypanocidal activity.
• It’s worth noting that a thorough transcriptomics approach – the study of all RNA molecules in a cell – is still required to properly understand the drug’s mechanism of action on a molecular level.